Royalty Pharma PLC (RPRX)
28.36
+0.38
(+1.38%)
USD |
NASDAQ |
May 10, 12:19
Royalty Pharma Free Cash Flow: 2.988B for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.988B |
| September 30, 2023 | 2.785B |
| June 30, 2023 | 2.750B |
| March 31, 2023 | 2.718B |
| December 31, 2022 | 2.144B |
| September 30, 2022 | 2.064B |
| June 30, 2022 | 1.995B |
| March 31, 2022 | 1.952B |
| December 31, 2021 | 2.018B |
| Date | Value |
|---|---|
| September 30, 2021 | 2.093B |
| June 30, 2021 | 2.132B |
| March 31, 2021 | 2.090B |
| December 31, 2020 | 2.035B |
| September 30, 2020 | 3.136B |
| June 30, 2020 | 1.858B |
| March 31, 2020 | 1.705B |
| December 31, 2019 | 1.667B |
Free Cash Flow Range, Past 5 Years
1.667B
Minimum
Dec 2019
3.136B
Maximum
Sep 2020
2.243B
Average
2.090B
Median
Mar 2021
Free Cash Flow Benchmarks
| Viatris Inc | 2.325B |
| Amgen Inc | 7.098B |
| Arrowhead Pharmaceuticals Inc | -402.70M |
| Pacira BioSciences Inc | 173.19M |
| Maravai LifeSciences Holdings Inc | 60.67M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 772.63M |
| Cash from Investing (Quarterly) | -1.000B |
| Cash from Financing (Quarterly) | -231.89M |
| Free Cash Flow Per Share (Quarterly) | 1.293 |
| Free Cash Flow to Equity (Quarterly) | 768.54M |
| Free Cash Flow to Firm (Quarterly) | 813.38M |
| Free Cash Flow Yield | 17.48% |